NCT02276495 - Can Single-Injection Adductor Canal Blocks Improve PostOp Pain Relief in Patients Undergoing Total Knee Arthroplasty? | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

June 20, 2020

Study Completion Date

September 30, 2024

Conditions

Pain Management

Interventions

OTHER

ACB Control - 20 ml saline injection for ACB

Adductor Canal Block Control (20 ml saline injection)

DRUG

ACB Study - 20 ml 0.5% Ropivacaine for Adductor Canal Block

Adductor Canal Block Study (20 ml 0.5% Ropivacaine)

DRUG

Local infiltration - 100 mLs of a solution containing: Ropivacaine + Epinephrine + Ketorolac + Clonidine + 0.9% Normal saline

"100 mLs of a solution containing:~Ropivacaine 2 mg/mL (49.25 mL) + Epinephrine 1 mg/mL (0.5 mL) + Ketorolac 30mg/mL (1mL) + Clonidine 100 mcg/mL (0.8 mL) + 0.9% Normal saline (48.45 mL)"

Trial Locations (1)

92868

University of California, Irvine Medical Center, Orange

All Listed Sponsors

lead

University of California, Irvine

OTHER